Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

AGNES C SANTOSA

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1689690927
CMS profile
667724
Location
SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$141,015.00

136 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $141,015.00 136

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $141,015.00 136

Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

AGNES C SANTOSA

NPI 1689690927 · CMS profile ID 667724

Allopathic & Osteopathic Physicians / Radiology / Diagnostic Radiology

SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1689690927?year=2019&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
AGNES C SANTOSA, NPI 1689690927, CMS profile ID 667724. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1689690927?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). AGNES C SANTOSA, NPI 1689690927, CMS profile ID 667724. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1689690927?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
AGNES C SANTOSA, NPI 1689690927, CMS profile ID 667724, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1689690927?year=2019&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

136 matching records · $141,015.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 136 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 136.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme Corporation $60.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832661 CMS
Merck Sharp & Dohme Corporation $75.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832759 CMS
Merck Sharp & Dohme Corporation $840.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832761 CMS
Merck Sharp & Dohme Corporation $1,260.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832771 CMS
Merck Sharp & Dohme Corporation $135.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832881 CMS
Merck Sharp & Dohme Corporation $1,685.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832887 CMS
Merck Sharp & Dohme Corporation $180.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832895 CMS
Merck Sharp & Dohme Corporation $180.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832897 CMS
Merck Sharp & Dohme Corporation $2,520.0009/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695833191 CMS
Merck Sharp & Dohme Corporation $2,220.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832521 CMS
Merck Sharp & Dohme Corporation $2,280.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832523 CMS
Merck Sharp & Dohme Corporation $2,520.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832529 CMS
Merck Sharp & Dohme Corporation $300.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832531 CMS
Merck Sharp & Dohme Corporation $420.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832649 CMS
Merck Sharp & Dohme Corporation $480.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832653 CMS
Merck Sharp & Dohme Corporation $540.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832655 CMS
Merck Sharp & Dohme Corporation $75.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832663 CMS
Merck Sharp & Dohme Corporation $660.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832765 CMS
Merck Sharp & Dohme Corporation $1,680.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832885 CMS
Merck Sharp & Dohme Corporation $180.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832889 CMS
Merck Sharp & Dohme Corporation $180.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832891 CMS
Merck Sharp & Dohme Corporation $180.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832893 CMS
Merck Sharp & Dohme Corporation $1,920.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695833003 CMS
Merck Sharp & Dohme Corporation $180.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695831775 CMS
Merck Sharp & Dohme Corporation $365.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832535 CMS
Merck Sharp & Dohme Corporation $375.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832647 CMS
Merck Sharp & Dohme Corporation $60.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832657 CMS
Merck Sharp & Dohme Corporation $960.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832763 CMS
Merck Sharp & Dohme Corporation $125.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832767 CMS
Merck Sharp & Dohme Corporation $125.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832769 CMS
Merck Sharp & Dohme Corporation $1,560.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695832883 CMS
Merck Sharp & Dohme Corporation $1,800.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695833001 CMS
Merck Sharp & Dohme Corporation $1,980.0007/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695833097 CMS
Merck Sharp & Dohme Corporation $3,060.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695699731 CMS
Merck Sharp & Dohme Corporation $360.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695699735 CMS
Merck Sharp & Dohme Corporation $420.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695699737 CMS
Merck Sharp & Dohme Corporation $780.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695699739 CMS
Merck Sharp & Dohme Corporation $9,570.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695699741 CMS
Merck Sharp & Dohme Corporation $1,320.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695701157 CMS
Merck Sharp & Dohme Corporation $150.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695701159 CMS
Merck Sharp & Dohme Corporation $1,740.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695701165 CMS
Merck Sharp & Dohme Corporation $180.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695701265 CMS
Merck Sharp & Dohme Corporation $2,760.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695701273 CMS
Merck Sharp & Dohme Corporation $300.0006/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695701277 CMS
Merck Sharp & Dohme Corporation $3,240.0005/08/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695699733 CMS
Merck Sharp & Dohme Corporation $1,020.0005/08/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695700837 CMS
Merck Sharp & Dohme Corporation $1,020.0005/08/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695700839 CMS
Merck Sharp & Dohme Corporation $120.0005/08/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695700845 CMS
Merck Sharp & Dohme Corporation $1,500.0005/08/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695701161 CMS
Merck Sharp & Dohme Corporation $180.0005/08/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695701263 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $141,015.00 136
PY2020 $313,495.00 208
PY2021 $428,992.50 204

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $80,696.36 24
PY2024 Recipient $10,094.79 3
PY2024 Principal investigator $103,495.74 14
PY2022 Recipient $382,620.00 18
PY2021 Recipient $352,040.00 17
PY2020 Recipient $454,485.00 15
PY2019 Recipient $544,712.50 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

24 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient GlaxoSmithKline, LLC. $4,252.13 10/15/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192157788
Recipient GlaxoSmithKline, LLC. $2,684.68 09/16/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192103309
Recipient GlaxoSmithKline, LLC. $2,684.68 09/16/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192157758
Recipient GlaxoSmithKline, LLC. $2,401.20 08/10/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192103332
Recipient GlaxoSmithKline, LLC. $2,501.25 07/15/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192103290
Recipient GlaxoSmithKline, LLC. $318.85 07/15/2025 Covered Recipient Physician A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192157792
Recipient GlaxoSmithKline, LLC. $2,238.48 06/11/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192103276
Recipient GlaxoSmithKline, LLC. $562.50 06/11/2025 Covered Recipient Physician A PHASE 2, RANDOMIZED, OPEN-LABEL, PLATFORM STUDY UTILIZING A MASTER P No dispute reported 06/30/2026 1192103296
Recipient GlaxoSmithKline, LLC. $1,667.50 05/13/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192103327
Recipient GlaxoSmithKline, LLC. $3,262.50 05/13/2025 Covered Recipient Physician A PHASE 2, RANDOMIZED, OPEN-LABEL, PLATFORM STUDY UTILIZING A MASTER P No dispute reported 06/30/2026 1192157763
Recipient GlaxoSmithKline, LLC. $1,629.45 05/13/2025 Covered Recipient Physician A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192157783
Recipient GlaxoSmithKline, LLC. $7,441.00 04/15/2025 Covered Recipient Physician A PHASE 2, RANDOMIZED, OPEN-LABEL, PLATFORM STUDY UTILIZING A MASTER P No dispute reported 06/30/2026 1192103270
Recipient GlaxoSmithKline, LLC. $908.50 04/15/2025 Covered Recipient Physician A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192104741
Recipient GlaxoSmithKline, LLC. $2,934.80 04/15/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192157767
Recipient GlaxoSmithKline, LLC. $761.25 03/13/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192103302
Recipient GlaxoSmithKline, LLC. $15,149.50 03/13/2025 Covered Recipient Physician A PHASE 2, RANDOMIZED, OPEN-LABEL, PLATFORM STUDY UTILIZING A MASTER P No dispute reported 06/30/2026 1192103320
Recipient GlaxoSmithKline, LLC. $1,340.57 03/11/2025 Covered Recipient Physician A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192103282
Recipient GlaxoSmithKline, LLC. $8,552.63 02/12/2025 Covered Recipient Physician A PHASE 2, RANDOMIZED, OPEN-LABEL, PLATFORM STUDY UTILIZING A MASTER P No dispute reported 06/30/2026 1192104735
Recipient GlaxoSmithKline, LLC. $1,625.00 02/12/2025 Covered Recipient Physician A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192157779
Recipient GlaxoSmithKline, LLC. $362.50 02/12/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192157797
Recipient Ipsen Innovation $75.00 02/06/2025 Covered Recipient Physician A Phase II, Randomized, Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics (PK) of Maintenance Cabozantinib (XL184) Plus Best Supportive Care (BSC) Versus BSC in Children, Adolescents and Young Adults (AYA) With Unresectable Residual Osteosarcoma Either at Diagnosis or at First Relapse After Standard Treatment No dispute reported 06/30/2026 1184302781
Recipient GlaxoSmithKline, LLC. $14,850.00 01/15/2025 Covered Recipient Physician A PHASE 2, RANDOMIZED, OPEN-LABEL, PLATFORM STUDY UTILIZING A MASTER P No dispute reported 06/30/2026 1192103314
Recipient GlaxoSmithKline, LLC. $1,408.52 01/15/2025 Covered Recipient Physician A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192157771
Recipient GlaxoSmithKline, LLC. $1,083.87 01/15/2025 Covered Recipient Physician A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF PERIOPERATIVE DOSTARLIMAB M No dispute reported 06/30/2026 1192157775